ReviewDrugs2015

Emerging Agents for the Treatment of Advanced, Imatinib-Resistant Gastrointestinal Stromal Tumors: Current Status and Future Directions.

Sebastian Bauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.